» Articles » PMID: 22287716

Distinct Kinetics of Gag-specific CD4+ and CD8+ T Cell Responses During Acute HIV-1 Infection

Abstract

HIV infection is characterized by a gradual deterioration of immune function, mainly in the CD4 compartment. To better understand the dynamics of HIV-specific T cells, we analyzed the kinetics and polyfunctional profiles of Gag-specific CD4(+) and CD8(+) T cell responses in 12 subtype C-infected individuals with different disease-progression profiles, ranging from acute to chronic HIV infection. The frequencies of Gag-responsive CD4(+) and CD8(+) T cells showed distinct temporal kinetics. The peak frequency of Gag-responsive IFN-γ(+)CD4(+) T cells was observed at a median of 28 d (interquartile range: 21-81 d) post-Fiebig I/II staging, whereas Gag-specific IFN-γ(+)CD8(+) T cell responses peaked at a median of 253 d (interquartile range: 136-401 d) and showed a significant biphasic expansion. The proportion of TNF-α-expressing cells within the IFN-γ(+)CD4(+) T cell population increased (p = 0.001) over time, whereas TNF-α-expressing cells within IFN-γ(+)CD8(+) T cells declined (p = 0.005). Both Gag-responsive CD4(+) and CD8(+) T cells showed decreased Ki67 expression within the first 120 d post-Fiebig I/II staging. Prior to the disappearance of Gag-responsive Ki67(+)CD4(+) T cells, these cells positively correlated (p = 0.00038) with viremia, indicating that early Gag-responsive CD4 events are shaped by viral burden. No such associations were observed in the Gag-specific CD8(+) T cell compartment. Overall, these observations indicated that circulating Gag-responsive CD4(+) and CD8(+) T cell frequencies and functions are not synchronous, and properties change rapidly at different tempos during early HIV infection.

Citing Articles

Vaccines: Underlying Principles of Design and Testing.

Kallon S, Samir S, Goonetilleke N Clin Pharmacol Ther. 2021; 109(4):987-999.

PMID: 33705574 PMC: 8048882. DOI: 10.1002/cpt.2207.


The HIV-1 latent reservoir is largely sensitive to circulating T cells.

Warren J, Zhou S, Xu Y, Moeser M, MacMillan D, Council O Elife. 2020; 9.

PMID: 33021198 PMC: 7593086. DOI: 10.7554/eLife.57246.


Evaluation of HIV-specific T-cell responses in HIV-infected older patients with controlled viremia on long-term antiretroviral therapy.

Behrens N, Wertheimer A, Love M, Klotz S, Ahmad N PLoS One. 2020; 15(9):e0236320.

PMID: 32941433 PMC: 7498024. DOI: 10.1371/journal.pone.0236320.


Defining Kinetic Properties of HIV-Specific CD8⁺ T-Cell Responses in Acute Infection.

Yang Y, Ganusov V Microorganisms. 2019; 7(3).

PMID: 30836625 PMC: 6462943. DOI: 10.3390/microorganisms7030069.


CD4 T-Cell Responses in Primary HIV Infection: Interrelationship with Immune Activation and Virus Burden.

Chevalier M, Didier C, Girard P, Manea M, Campa P, Barre-Sinoussi F Front Immunol. 2016; 7:395.

PMID: 27746782 PMC: 5040706. DOI: 10.3389/fimmu.2016.00395.


References
1.
Addo M, Yu X, Rathod A, Cohen D, Eldridge R, Strick D . Comprehensive epitope analysis of human immunodeficiency virus type 1 (HIV-1)-specific T-cell responses directed against the entire expressed HIV-1 genome demonstrate broadly directed responses, but no correlation to viral load. J Virol. 2003; 77(3):2081-92. PMC: 140965. DOI: 10.1128/jvi.77.3.2081-2092.2003. View

2.
BRODIE S, Patterson B, Lewinsohn D, Diem K, Spach D, Greenberg P . HIV-specific cytotoxic T lymphocytes traffic to lymph nodes and localize at sites of HIV replication and cell death. J Clin Invest. 2000; 105(10):1407-17. PMC: 315465. DOI: 10.1172/JCI8707. View

3.
Yue F, Kovacs C, Dimayuga R, Gu X, Parks P, Kaul R . Preferential apoptosis of HIV-1-specific CD4+ T cells. J Immunol. 2005; 174(4):2196-204. DOI: 10.4049/jimmunol.174.4.2196. View

4.
Ramsburg E, Publicover J, Coppock D, Rose J . Requirement for CD4 T cell help in maintenance of memory CD8 T cell responses is epitope dependent. J Immunol. 2007; 178(10):6350-8. DOI: 10.4049/jimmunol.178.10.6350. View

5.
Lichterfeld M, Yu X, Le Gall S, Altfeld M . Immunodominance of HIV-1-specific CD8(+) T-cell responses in acute HIV-1 infection: at the crossroads of viral and host genetics. Trends Immunol. 2005; 26(3):166-71. DOI: 10.1016/j.it.2005.01.003. View